MedPath

Safety and Effectiveness of Cortical Stimulation in the Treatment of Stroke Patients With Upper Extremity Hemiparesis

Phase 3
Conditions
Stroke
Hemiparesis
Interventions
Other: Rehabilitation
Device: Cortical Stimulation and rehabilitation
Registration Number
NCT00170716
Lead Sponsor
Northstar Neuroscience
Brief Summary

The purpose of this study is to assess the safety and effectiveness of cortical stimulation delivered concurrent with rehabilitation activities to enhance motor recovery in patients suffering from hemiparesis affecting the upper extremity following a stroke.

Detailed Description

Stroke is a leading cause of serious, long-term disability in the United States. According to the American Stroke Association, the prevalence of stroke in the U.S. is approximately 4.8 million with approximately 700,000 additional strokes occurring annually. The 2001 overall death rate for stroke was 58%. Of those who survive, 30 to 50 percent do not regain functional independence, 15 to 30 percent are permanently disabled, and 20% require institutional care at three months after onset.

The most common neurological deficit among these stroke survivors, and thus a substantial contributor to post-stroke disability, is a motor weakness on one (hemiparesis) side of the body. Presently, the only treatment available for patients with motor deficits is rehabilitative therapy. However, many patients are not responsive to standard rehabilitative therapy or achieve a less than satisfactory improvement in function.

The primary objective of this study is to determine the safety and effectiveness of targeted sub-threshold epidural cortical stimulation delivered concurrent with rehabilitation activities to enhance motor recovery in patients suffering from hemiparesis (a motor weakness in one half of the body) affecting the upper extremity (shoulder, arm, wrist, hand) following a stroke. In addition to evaluating changes from baseline level, safety and efficacy measures will be compared to patients who undergo the same rehabilitation activities but without cortical stimulation. The two study groups will be compared to determine the degree to which motor function of the affected limb can be improved beyond rehabilitation alone by epidural stimulation of a targeted cortical region.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
174
Inclusion Criteria
  • Subjects must have an ischemic stroke.
  • Moderate to moderately severe upper-extremity hemiparesis.
  • Aged 21 years or older.
Exclusion Criteria
  • Primary hemorrhagic stroke.
  • Any additional stroke associated with incomplete motor recovery.
  • Any neurologic or physical condition impairing function of the target extremity.
  • History of seizure disorder.
  • History of spinal cord injury, traumatic brain injury, or spontaneous subdural or epidural hematoma that has resulted in a neurologic deficit.
  • Contraindication to magnetic resonance (MR) imaging.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlRehabilitation-
InvestigationalCortical Stimulation and rehabilitation-
Primary Outcome Measures
NameTimeMethod
Arm Motor Fugl-Meyer (AMFM) scoreFollow Up Week 4
Arm Motor Ability Test (AMAT) scoreFollow Up Week 4
Secondary Outcome Measures
NameTimeMethod
Box and Block Test scoreFollow Up Week 4
Stroke Specific Quality of Life (SSQOL) scoreFollow Up Week 4
Serious adverse event rateFollow up week 4 and 6 months

Trial Locations

Locations (21)

University of Arizona Health Sciences Center

🇺🇸

Tucson, Arizona, United States

Mount Sinai School of Medicine

🇺🇸

New York, New York, United States

University of Florida, Jacksonville

🇺🇸

Jacksonville, Florida, United States

St. Luke's Hospital

🇺🇸

Kansas City, Missouri, United States

Northwestern University Medical Center and the Rehabilitation Institute of Chicago

🇺🇸

Chicago, Illinois, United States

University of Southern California

🇺🇸

Los Angeles, California, United States

University of California San Francisco Medical Center

🇺🇸

San Francisco, California, United States

Wayne State University

🇺🇸

Detroit, Michigan, United States

Colorado Neurological Institute & Swedish Medical Center

🇺🇸

Englewood, Colorado, United States

University of Illinois at Chicago

🇺🇸

Chicago, Illinois, United States

Spaulding Rehabilitation Center and Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

University of Pennsylvania Medical Center

🇺🇸

Philadelphia, Pennsylvania, United States

State University of New York Upstate Medical Center

🇺🇸

Syracuse, New York, United States

University of Cincinnati Medical Center

🇺🇸

Cincinnati, Ohio, United States

Oregon Health Sciences University

🇺🇸

Portland, Oregon, United States

University of Pittsburgh Medical Center

🇺🇸

Pittsburgh, Pennsylvania, United States

Swedish Health Services

🇺🇸

Seattle, Washington, United States

University of Texas Health Sciences Center at Houston

🇺🇸

Houston, Texas, United States

University of Utah Health Sciences Center

🇺🇸

Salt Lake City, Utah, United States

Emory Clinic

🇺🇸

Atlanta, Georgia, United States

Stanford University Medical Center

🇺🇸

Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath